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INTRODUCTION
Mood disorders, such as major depressive disorders and bi-
polar disorders, are common mental illnesses with a long-
time course.1,2 Patients with mood disorders usually experi-
ence impairments in important social roles and comorbidities 
with medical illnesses in addition to mood-related symp-
toms.2 Functional impairment or decrements in health-relat-
Print ISSN 1738-3684 / On-line ISSN 1976-3026
OPEN ACCESS
100  Copyright © 2017 Korean Neuropsychiatric Association  
ed quality of life associated with mood disorders were report-
ed to be greater than those associated with chronic medical 
conditions such as diabetes, arthritis, and chronic cardiac or 
pulmonary disease.3-5 Moreover, suicidal behavior and com-
mitment is a severe social problem, and it is more prevalent in 
mood disorders.6,7 
Kessler et al.8 reported mood disorder age of onset curves 
showing consistently low prevalence until the early teens, a 
rough increase through late middle age, and a declining in-
crease thereafter. Generally, the median age of onset for mood 
disorders is reported as a wide range (25–45 years old).8 Young-
er onset age is known to be one of the most replicated risk fac-
tors for the switch from depression to (hypo)mania or mixed 
states.9,10 It is crucial to investigate the clinical features and 
prognosis of early-onset mood disorders in order to under-
stand the pathophysiology and course of mood disorders in 
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general, including predicting factors of recurrence or switch-
ing, environmental factors, circadian rhythm characteristics, 
and biological mechanisms.
Most assessments in mood disorder research have included 
checking clinical symptoms at a series of scheduled visits. 
However, there may be various events and mood changes dur-
ing inter-visit periods, and clinicians and even patients could 
easily miss what happened during these inter-visit periods. 
Many researchers have tried to compensate for this possibility 
by using tools, such as a diary form.11-13 Recently, it has be-
come much more possible to assess the daily status of mood 
disorder patients with the development of information com-
munication technology (ICT).14-17 
We designed and are performing a longitudinal observa-
tional prospective cohort study for early-onset mood disorder 
patients called the Mood Disorder Cohort Research Consor-
tium (MDCRC) Study. The MDCRC Study is aimed to evalu-
ate demographic information, medical and psychiatric history, 
clinical features and courses, and prognosis of mood disorders 
by assessing patients every 3 months as well as during inter-
visit periods using the daily eMood chart smart phone appli-
cation. 
DESIGN AND METHODS 
Purposes
The main purpose of the MDCRC study is to investigate 
demographic information, medical and psychiatric history, 
clinical characteristics, course, and prognosis, as well as assess 
the risk factors or preventive factors associated with relapse or 
recovery or diagnostic conversion from unipolar depressive 
disorder to bipolar disorder targeting early-onset mood dis-
orders. Additionally, the MDCRC study aims to facilitate 
translational research for mood disorders and to provide a re-
source for the study of mood disorders, such as bridging trans-
lational research and ICT convergence research on mood disor-
ders by utilizing unique resources. Furthermore, the additional 
purpose of the MDCRC is to present a new methodology of 
mood disorders research. By complementing the shortcom-
ings of the various mood disorders studies that have been con-
ducted so far, our team aims to develop and perform specific 
research methods that reflect the clinical aspects of mood 
disorders. 
Cohort populations
The MDCRC study recruits mood disorder patients who 
fulfill the criteria of the Diagnostic and Statistical Manual of 
Mental Disorders, Fifth Edition (DSM-5) for major depres-
sive disorder, bipolar I disorder, or bipolar II disorder.18 Gen-
erally, mood disorder patients do not receive treatment from 
the beginning of major mood symptoms for several rea-
sons.19-22 In fact, mood disorder patients initially visit psychiat-
ric clinics and are diagnosed after a considerable period of 
time from the initial experience of major mood symptoms.19-22 
Early mood disorder is defined as follows: 1) under 25 years 
old with mood disorder; or 2) under 35 years old with mood 
disorder within 2 years of treatment. We exclude patients 
with intellectual disability or organic brain injury, and/or dif-
ficulty reading and understanding the Korean language.
Study design
The assessment schedule consists of the baseline assess-
ment, inter-visit assessment, and follow-up assessment. The 
overall configuration of the MDCRC study is depicted in Table 
1. The follow-up assessment is divided into formal assessment 
and telephone-based assessment according to the evaluation 
methods and into scheduled visit assessment and unscheduled 
visit assessment depending on the time of evaluation. Tele-
Table 1. The overall configuration of the MDCRC study
Contents Time Raters
Baseline assessment Baseline evaluation Baseline Clinicians
Research staff
Patients
Blood sampling Baseline Research staff
Inter-visit assessments Daily mood diary Every routine day during inter-visit period Patients
Inter-visit mood chart validation Follow-up visit Clinicians
Inter-visit mood episode evaluation Follow-up visit Clinicians
Follow-up assessment Follow-up evaluation Follow-up visit Clinicians
Research staff
Patients
Telephone-based follow-up evaluation Follow-up visit Research staff
MDCRC: Mood Disorder Cohort Research Consortium 
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phone-based assessment could be used only for limited cases 
when patients cannot visit the hospital for acceptable reasons, 
and it is contrived to reduce drop-out from the study. Sched-
uled visits for follow-up assessments are performed every 12 
weeks from the baseline assessment. For inter-visit assess-
ments, all the subjects are dictated to check a daily mood chart 
using the eMood chart application for smartphones or person-
al computers. If it is not applicable, the eMood chart is replaced 
by a paper mood diary. The daily mood chart is an important 
component of the inter-visit assessment. Patients are provid-
ed a daily mood chart that asks for mood state (-3 to +3), en-
ergy level (-3 to +3), anxiety (0–3), irritability (0–3), drinking 
(yes or no), prescription medication use (yes or no), total 
sleep time (hours), weight (once every two weeks), and men-
struation (only for women). A trained psychiatrist reviews 
the records of the daily mood charts at every visit at an out-
patient clinic or at the follow-up assessments. By reviewing 
daily mood charts and interviewing patients, the psychiatrist 
validates the daily mood chart and sometimes can modify 
the mood chart according to the judgment of the clinician. 
This process is called “inter-visit mood chart validation.” After 
the inter-visit mood chart validation process, a psychiatrist 
determines whether there have been possibilities of major or 
minor mood episodes during the inter-visit period. When a 
major or minor mood episode is suspected from the daily 
mood chart validation, investigators proceed to the next step 
called “inter-visit mood episode evaluation.” At the inter-visit 
mood episode evaluation step, clinicians ask patients about 
mood episodes according to DSM-5 criteria and establish a 
most recent diagnosis. If a major or minor mood episode is 
not suspected from the inter-visit mood chart validation, in-
vestigators skip the mood episode evaluation step and finish 
the follow-up assessment. Overall design of the MDCRC 
study is presented in Figure 1. 
The MDCRC study started in September 2014 and will be 
sustained for at least 5 years. Since mood disorders have chronic 
and various clinical courses, many diagnosed cases of unipolar 
depression are known to change to bipolar disorder. It is very 
important to follow-up for long-term periods in the course of 
mood disorders, and we want to follow-up as long as possible.
Assessments 
Various assessments are performed at each visit starting 
from the baseline assessment. At first, screening evaluations 
for inclusion and exclusion criteria for the MDCRC Study are 
performed. After successful screening, at every visit thereafter, 
clinicians have to check and write down patients’ most recent 
diagnosis according to the DSM-5.18 Assessment is composed 
of demographic and clinical data, psychiatric assessment by 
investigators and patients, and biological assessment, which 
is the same as mentioned below (Table 2).
Demographic and clinical data
The demographic data at baseline assessment consists of 
age, gender, height, weight, waist circumstance, handedness, 
and socioeconomic status, such as the average monthly in-
come, education level, marital status with children, and kinds 
of jobs. 
The sleep pattern was assessed by asking the sleep onset 
time, wake-up time, sleep latency time, total sleep time, and 
nap time. Almost all questions asked are divided by week-
days and weekends. 
Medication history is precious information to understand 
patients with mood disorders. However, it is very difficult to 
investigate prescribed past medication history for treatment 
of mood disorders. We decided to investigate only whether 
the patients have been prescribed lithium for treatment in-
stead of conducting a full investigation of medication history. 
If the patients have experiences of lithium medication, the cli-
nician checks the ALDA scale for evaluating the responsive-
ness of lithium treatment.23,24 All psychiatric medication is re-
corded from the baseline assessment and at every follow-up 
assessment by checking the patients’ medication compliance, 
which is the percentage of real medicated drugs among pre-
Figure 1. The overall design of the MD-
CRC study. MDCRC: Mood Disorder 
Cohort Research Consortium.
Daily mood 
chart
Inter-visit mood 
chart validation
Follow-up
assessment
Inter-visit mood 
episode evaluation
No
Suspect  
major or minor 
mood episode?
Yes, suspected
Scheduled visit
Unscheduled visit
Baseline  
assessment
CH Cho et al.
   www.psychiatryinvestigation.org  103
scribed drugs.
We investigate whether the patients have history of suicide 
attempts. If there has been history of suicide attempts, then pa-
tients are asked the age of the first attempted suicidal event and 
the number of suicidal attempts with or without mood epi-
sodes. Suicidal history is also assessed at every follow-up visit 
for investigation of inter-visit suicidal events. 
Familial psychiatric history is assessed by asking for psychi-
atric treatment history, such as bipolar disorder, depressive 
disorder, alcohol and substance use disorders, anxiety disor-
ders, schizophrenic spectrum disorders, and other psychiatric 
problems, including suicide. 
The medical and surgical history is asked for assessment of 
past and current comorbidities. Moreover, average monthly 
cost of treatment is assessed for psychiatric, medical, dental, 
and oriental medicinal managements as well as medical us-
age patterns at every assessment. Smoking and alcohol history 
including duration and quantity of the uses is also checked for 
all patients at every assessment. Evaluation of menopause state 
is performed only for female participants. 
Psychiatric assessment by investigators
The Korean version of the Mini-International Neuropsy-
chiatric Interview (MINI) was used for psychiatric diagnosis 
by clinicians who are expert in psychiatry at the baseline assess-
ment.25 Patients with mood disorders often suffer from co-
morbid psychiatric symptoms. Psychiatric comorbidity was as-
sessed by the same clinicians at every visit from the baseline 
assessment to catch newly developed psychiatric problems.
Routine mood symptom scales including the Montgom-
Table 2. Assessment items of the MDCRC study
Assessment items Baseline assessment Follow-up assessment
Inclusion and exclusion criteria √
Most recent diagnosis √ √
Demographic and Socioeconomic state √
Information on first-onset episode and total episodes √
Sleep pattern √ √
Medical history √ √
Recent medical usage patterns and monthly average medical expenses √ √
MINI International Neuropsychiatric Interview √
Psychiatric co-morbidity √ √
Suicidal history √ √
History of psychiatric medication and drug compliance √ √
ALDA questionnaire for Lithium treatment response √
Familial psychiatric history √
Montgomery-Åsberg Depression Rating Scale √ √
Young Mania Rating Scale √ √
Clinical Global Impression-Bipolar √ √
Biological Rhythms Interview of Assessment in Neuropsychiatry √ √
Quick Inventory of Depressive Symptomatology √ √
Hypomania Symptom Checklist-32 √ √
Mood Disorder Questionnaire √ √
Barratt Impulsiveness Scale √ √
Composite Scale of Morningness √ √
Korean Version of Drug Attitude Inventory-10 √
Seasonal Pattern Assessment Questionnaire √ √
Korean version of WHO Quality of Life Scale abbreviated version √ √
The International Physical Activity Questionnaire-Short Form √ √
Life Experiences Survey √ √
Biological assessment (Blood sampling) √
MDCRC: Mood Disorder Cohort Research Consortium
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ery-Åsberg Depression Rating Scale (MADRS) for depressive 
symptoms26 and the Young Mania Rating Scale (YMRS) for 
manic symptoms27 are applied. The Biological Rhythms Inter-
view of Assessment in Neuropsychiatry (BRIAN) is checked 
to evaluate circadian rhythm tendencies in participants.28 The 
Clinical Global Impression-Bipolar (CGI-BP) Scale is also in-
vestigated by clinicians at every assessment.29 
Psychiatric assessment by patients (self-report)
There are various self-report scales for evaluating patients’ 
psychiatric state and history. We selected the self-report forms 
and subjective scales that are considered to be important for 
the study of patients with mood disorders. The Quick Inven-
tory of Depressive Symptomatology,30 Hypomania Symptom 
Checklist-32,31 and Mood Disorder Questionnaire32 are pro-
vided to patients for assessing mood symptoms such as de-
pression, anxiety, hypomania, or bipolarity phenotypes. The 
Barratt Impulsiveness Scale33 is applied for evaluating other 
important states closely related to mood problems. The Kore-
an Version of Drug Attitude Inventory-10 is checked once for 
evaluating patient’s compliance with biological treatment at 
baseline assessment.34 For evaluating patients’ seasonality and 
chronotype, the Seasonal Pattern Assessment Questionnaire35 
and Composite Scale of Morningness36 are provided at every 
visit. The Korean version of WHO Quality of Life Scale ab-
breviated version is asked for subjective perception of quality 
of life in patients with mood disorders.37 General physical ac-
tivity is another important aspect of mood disorders, so we 
apply The International Physical Activity Questionnaire-Short 
Form.38 Since various events occur in routine life and perceived 
stress from the events could affect the prognosis of mood disor-
ders, the Life Experiences Survey is checked by each patient at 
every assessment.39 
Blood sample collection
Blood sample collection from all participants is performed 
once at the baseline enrollment of the study. Blood samples (10 
mL) are collected into ethylenediaminetetraacetic acid (EDTA) 
bottles and stored in a -30°C freezer. They will be used for ge-
nomic analyses or other biological analyses.
Database management and analyses
Clinical data are registered electronically via an electronic 
case report form based on the Internet-based Clinical Re-
search and Trial Management System (iCReaT) established by 
the Centers for Disease Control and Prevention, Ministry of 
Health and Welfare, Republic of Korea (iCReaT, Study No. 
C150010). The data will be encrypted, and it will have limit-
ed access that is managed by iCReaT data managers. 
There could be various objects for analysis from the MD-
CRC Study. We will use various statistical analysis methods 
depending on the characteristics of data and each hypothesis. 
For the analysis of demographic, clinical features, prognosis 
(including predictors and medical usage between different 
clinical groups of mood disorders), we will use paired t-test, 
logistic regression analysis, repeated measures ANOVA, Cox 
proportional hazard regression, and so on. For the analysis of 
longitudinal data of clinical symptom changes, mixed linear 
models taking into account the correlation between the differ-
ent assessment variables of mood disorder patients in the course 
of the cohort study assessment schedule will be used.
Collaboration with a study using wearable activity 
trackers 
Because one of the study’s purposes is to facilitate transla-
tional research for mood disorders, the MDCRC study has a 
collaboration with a circadian rhythm study of mood disor-
ders using a wearable activity tracker. The study participants 
also participate in the wearable activity tracker study when 
they want to join. Various variables such as activity, sleep, and 
heart rate will be obtained from wearable activity tracker. The 
MDCRC study is aimed to have further collaborations with 
translational research such as ICT convergence research on 
mood disorders.
CONCLUSION
Until now, various cohort studies of mood disorders have 
been conducted to investigate clinical and biological infor-
mation. Each cohort study of mood disorders had their own 
purposes and methods, such as naturalistic cohort studies 
with clinical populations or with community populations and 
cohort studies with clinical populations designed for clinical 
trials.40 Because mood disorders are characterized as long-
lasting with repeating recurrence and impairment of social 
functioning,1,2 it is still necessary to perform cohort studies for 
mood disorders with various purposes and methods. Based on 
the review of previously performed cohort studies for mood 
disorders, we designed and are performing a cohort study fo-
cusing on early mood disorders to investigate demographic 
information, medical and psychiatric clinical features, medical 
usage pattern and medical expenses, and prognosis, including 
diagnostic conversion from unipolar to bipolar disorder of pa-
tients by assessments at scheduled visits as well as during inter-
visit periods. From the design and methods of the MDCRC 
study, it is expected to overcome some limitations of previ-
ously performed cohort studies for mood disorders, through 
daily mood chart evaluation for assessment of inter-visit pe-
riods, unscheduled visit to catch up aggravation of the symp-
toms, and using ICT methods. We look forward to getting an 
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enormous amount of clinical and biological information con-
cerning mood disorders, to help translational research through 
the resource of our cohort study, and to present a research 
methodology reflecting the characteristics of mood disorders.
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